
The Full Spectrum of Life Sciences.
We bring deep, specialized expertise across every major life sciences vertical — understanding the unique regulatory, clinical, and commercial dynamics of each.
Pharmaceuticals
Small molecule drug development from hit-to-lead through lifecycle management, including generics and specialty pharma strategy.
Biotechnology
Biologics, monoclonal antibodies, and biosimilar programs with deep understanding of CMC complexity and regulatory nuance.
Medical Devices
Class I through Class III devices across cardiovascular, orthopedic, neurological, and surgical specialties.
Cell Therapy
Autologous and allogeneic cell therapy programs including CAR-T, TCR, TIL, and stem cell-derived therapies.
Gene Therapy
AAV, lentiviral, and next-generation gene therapy platforms with expertise in rare disease and orphan drug strategy.
Diagnostics
In vitro diagnostics, companion diagnostics, and laboratory developed tests across molecular, immunoassay, and imaging modalities.
Digital Health
Software as a Medical Device (SaMD), digital therapeutics, AI/ML-enabled diagnostics, and remote patient monitoring.
Combination Products
Drug-device, biologic-device, and drug-device-biologic combinations requiring coordinated regulatory and development strategies.